The ordering and performance of clinical FDG-PET/CT scans is complicated due to insurance coverage, reimbursement issues related to Medicare beneficiaries, and whether the patient is participating in an IRB approved clinical trial. The majority of these clinical PET/CT scans are performed in the Huntsman Cancer Hospital on the 3rd floor.

If the patient is on a research study where the FDG-PET/CT scans are part of an approved IRB study and standard of care they are most often performed in the Center for Quantitative Cancer Imaging. This is due to the fact that the patient is on a research study and the PET/CT acquisition parameters are often defined and the FDG uptake time may defined.

In addition, the images are often sent for central review and additional post-processing may be required per the study protocol.


Contact Us

Center for Quantitative Cancer Imaging Director
John M. Hoffman, MD


HCI Senior Director Oversight
Cornelia Ulrich, MS, PhD

Faculty Advisory Committee Chair
David Goldgar, PhD

Faculty Advisory Committee Members
Lisa Aspinwall, PhD
Saundra Buys, MD
Matthew Firpo, PhD
Kimberly Kaphingst, PhD
Deborah Neklason, PhD
Erin Rothwell, MS, PhD
Joshua Schiffman, MD
Theresa Werner, MD